Integral Diagnostics Price Target Cut 7.4% to A$3.15/Share by Barrenjoey

Dow Jones04:50

Integral Diagnostics Price Target Raised 1.4% to A$3.50/Share by RBC Capital Markets

Dow JonesJan 30 06:41

Jarden Sticks to Its Buy Rating for Integral Diagnostics Ltd. (IDX)

TipRanksDec 13, 2024 06:38

Jarden Adjusts Integral Diagnostics' Price Target to AU$3.68 From AU$3.72, Keeps at Buy

MT NewswiresDec 11, 2024 16:13

Integral Diagnostics Ltd. (IDX) Receives a Hold From Canaccord Genuity

TipRanksSep 25, 2024 15:09

Integral Diagnostics Price Target Raised 10% to A$3.30/Share by Ord Minnett

Dow JonesSep 25, 2024 14:08

Ord Minnett Sticks to Their Buy Rating for Integral Diagnostics Ltd. (IDX)

TipRanksAug 28, 2024 13:05

Integral Diagnostics Raised to Overweight From Mkt Weight by Wilsons >IDX.AU

Dow JonesAug 28, 2024 07:04

Morgan Stanley Adjusts Integral Diagnostics' Price Target to AU$1.85 From AU$1.70, Keeps at Underweight

MT NewswiresMar 6, 2024 10:07

Jarden Research Adjusts Integral Diagnostics' Price Target to AU$2.59 From AU$2.54, Keeps at Neutral

MT NewswiresFeb 21, 2024 09:31

Analysts Offer Insights on Healthcare Companies: Integral Diagnostics Ltd. (AU:IDX), Biophytis SA (Stuttgart: DE:6XB) and Merck KGaA (GB:0O14)

TipRanksMay 12, 2023 17:04